MedTrace Logo

Crestal Sinus Lifting in Periodontally-Compromised Patients Utilizing Autologous Dentin Graft

NCT06887582 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-04-22

No results posted yet for this study

Summary

The integration of artificial intelligence and computer-guided technology offers the potential for improving surgical accuracy, reducing complications, and enhancing outcomes. Additionally, advancements such as electromagnetic mallets for bone manipulation and autologous dentin grafts provide promising alternatives for bone regeneration. This study aims to combine these technologies to assess the efficacy and clinical outcomes of AI-assisted, computer-guided crestal sinus lifting with immediate implant placement in periodontally compromised sites.

Conditions

  • Maxillary Sinus Disease
  • Alveolar Bone Loss

Interventions

PROCEDURE

Free-hand sinus lift augmanted by particulate autologous dentin graft + free-hand implant placement

The sinus will be lifted and augmented by particulate autologous dentin graft followed by simultaneous free-hand implant placement

PROCEDURE

AI-assisted/computer-guided sinus lift augmanted by particulate autologous dentin graft + computer-guided implant placement

The sinus will be lifted and augmented by particulate autologous dentin graft followed by simultaneous implant placement. all the procedures will be computer-guided with assistance of artificial intelligence

PROCEDURE

Free-hand sinus lift with autologous dentin block graft +free-hand immediate implant placement

The sinus will be lifted and augmented by autologous block dentin graft followed by simultaneous free-hand implant placement

PROCEDURE

AI-assisted/computer-guided sinus lift with autologous dentin block graft +computer-guided immediate implant placement.

The sinus will be lifted and augmented by autologous block dentin graft followed by simultaneous implant placement. all the procedures will be computer-guided with assistance of artificial intelligence

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-21
Primary Completion
2026-03-30
Completion
2026-04-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06887582 on ClinicalTrials.gov